ZA201500606B - Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine - Google Patents

Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine

Info

Publication number
ZA201500606B
ZA201500606B ZA2015/00606A ZA201500606A ZA201500606B ZA 201500606 B ZA201500606 B ZA 201500606B ZA 2015/00606 A ZA2015/00606 A ZA 2015/00606A ZA 201500606 A ZA201500606 A ZA 201500606A ZA 201500606 B ZA201500606 B ZA 201500606B
Authority
ZA
South Africa
Prior art keywords
mva
rsv
vaccine
respiratory syncytial
modified vaccinia
Prior art date
Application number
ZA2015/00606A
Inventor
Cheminay Cédric
Steigerwald Robin
Chaplin Paul
Original Assignee
Bavarian Nordic As A Company Incorporated In Denmark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/055483 external-priority patent/WO2014019718A1/en
Application filed by Bavarian Nordic As A Company Incorporated In Denmark filed Critical Bavarian Nordic As A Company Incorporated In Denmark
Publication of ZA201500606B publication Critical patent/ZA201500606B/en

Links

ZA2015/00606A 2012-08-01 2015-01-27 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine ZA201500606B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261678367P 2012-08-01 2012-08-01
EP12005594 2012-08-01
PCT/EP2013/055483 WO2014019718A1 (en) 2012-08-01 2013-03-15 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine

Publications (1)

Publication Number Publication Date
ZA201500606B true ZA201500606B (en) 2020-05-27

Family

ID=66440168

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/00606A ZA201500606B (en) 2012-08-01 2015-01-27 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine

Country Status (8)

Country Link
JP (2) JP6895944B2 (en)
DK (1) DK2879702T3 (en)
ES (1) ES2767324T3 (en)
HU (1) HUE047102T2 (en)
LT (1) LT2879702T (en)
PT (1) PT2879702T (en)
UA (1) UA123385C2 (en)
ZA (1) ZA201500606B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2879702T3 (en) * 2012-08-01 2020-02-24 Bavarian Nordic As RECOMBINANT MODIFIED VACCINIAVIRUS ANKARA (VAT) -VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008114149A2 (en) * 2007-03-21 2008-09-25 Id Biomedical Corporation Of Quebec Chimeric antigens
CA2770304C (en) * 2009-08-04 2019-11-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Anti-rsv immunogens and methods of immunization
US9173933B2 (en) * 2010-10-15 2015-11-03 Bavarian Nordic A/S Recombinant modified vaccinia virus Ankara influenza vaccine
WO2012085936A2 (en) * 2010-12-20 2012-06-28 Panacea Biotech Ltd Recombinant respiratory syncytial virus plasmids and vaccines
WO2012089231A1 (en) * 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
KR20220119527A (en) * 2012-08-01 2022-08-29 버베리안 노딕 에이/에스 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
DK2879702T3 (en) * 2012-08-01 2020-02-24 Bavarian Nordic As RECOMBINANT MODIFIED VACCINIAVIRUS ANKARA (VAT) -VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)

Also Published As

Publication number Publication date
DK2879702T3 (en) 2020-02-24
LT2879702T (en) 2020-02-10
HUE047102T2 (en) 2020-04-28
ES2767324T3 (en) 2020-06-17
PT2879702T (en) 2020-02-04
JP2019068833A (en) 2019-05-09
UA123385C2 (en) 2021-03-31
JP2021137023A (en) 2021-09-16
JP7317896B2 (en) 2023-07-31
JP6895944B2 (en) 2021-06-30

Similar Documents

Publication Publication Date Title
HK1205459A1 (en) Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine (mva)(rsv)
SG11201510746WA (en) Respiratory syncytial virus (rsv) vaccine
HK1222125A1 (en) Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus rsv f
IL258831A (en) Respiratory syncytial virus vaccine
AP2014007993A0 (en) Vaccine against RSV
PT2939692T (en) Nasal influenza vaccine composition
PT2806891T (en) Parainfluenza virus 5 based vaccines
GB2506621B (en) Respiratory mask
EP2432503A4 (en) Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva)
IL240504A0 (en) Combination vaccine for respiratory syncytial virus and influenza
EP2631290A4 (en) Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector
EP2940134A4 (en) Vaccine prepared utilizing human parainfluenza virus type 2 vector
EP2753354A4 (en) Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine
HK1223644A1 (en) Semi-live respiratory syncytial virus vaccine
EP3057611A4 (en) Thermostable respiratory synctial virus (rsv) vaccine compositions
EP3053593A4 (en) Nasal mucosal vaccine composition
HK1223643A1 (en) Semi-live respiratory syncytial virus vaccine
EP2929893A4 (en) Adjuvant for mucous membrane vaccine
EP3046578A4 (en) Recombinant respiratory syncytial virus (rsv) and vaccines
EP2839840A4 (en) Recombinant trivalent vaccine against human influenza
ZA201500606B (en) Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
GB201215184D0 (en) Therapeutic virus
HK1206272A1 (en) Vaccine against rsv rsv